UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 74

Sortiert nach

Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

The Lancet (British edition), 2008-06, Vol.371 (9630), p.2085-2092

2008

Volltextzugriff (PDF)

Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trial

Neurology, 2012-04, Vol.78 (14), p.1069

2012

Volltextzugriff (PDF)

cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity

Brain (London, England : 1878), 2003-05, Vol.126 (5), p.1048-1057

2003

Volltextzugriff (PDF)

Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor

The Journal of immunology (1950), 1990-01, Vol.144 (1), p.129

1990

Volltextzugriff (PDF)

Tumour necrosis factor and anti-tumour necrosis factor approach to inflammatory demyelinating diseases of the central nervous system

Annals of the rheumatic diseases, 2000-11, Vol.59 (suppl 1), p.i94-i102

Selmaj, Krzysztof W

2000

Volltextzugriff (PDF)

Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro

Annals of neurology, 1988-04, Vol.23 (4), p.339-346

1988

Volltextzugriff (PDF)

Multiple sclerosis: The increased frequency of the ICAM-1 exon 6 gene point mutation genetic type K469

Annals of neurology, 1998-07, Vol.44 (1), p.70-75

1998

Volltextzugriff (PDF)

Proton magnetic resonance spectroscopy of normal appearing white matter in familial and sporadic multiple sclerosis

Journal of neurology, 2005-07, Vol.252 (7), p.830-832

2005

Volltextzugriff (PDF)

Inducible Heat Shock Protein 70 Promotes Myelin Autoantigen Presentation by the HLA Class II

The Journal of immunology (1950), 2004-01, Vol.172 (1), p.202-213

2004

Volltextzugriff (PDF)

Shedding of TNF receptors in multiple sclerosis patients

Neurology, 1999-10, Vol.53 (7), p.1409

1999

Volltextzugriff (PDF)

Brain glycolipids suppress T helper cells and inhibit autoimmune demyelination

The Journal of neuroscience, 2014-06, Vol.34 (25), p.8646-8658

2014

Volltextzugriff (PDF)

Heat shock protein 70 associations with myelin basic protein and proteolipid protein in multiple sclerosis brains

International immunology, 2003-02, Vol.15 (2), p.241-249

2003

Volltextzugriff (PDF)

P486 Treatment-emergent COVID-19 infections in ozanimod ulcerative colitis and multiple sclerosis clinical trials

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i452-i452

2022

Volltextzugriff (PDF)

Experimental autoimmune encephalomyelitis: immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors

Neurology, 1995-06, Vol.45 (6 Suppl 6), p.S44

1995

Volltextzugriff (PDF)

Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study

Multiple sclerosis, 2010-11, Vol.16 (11), p.1360-1366

2010

Volltextzugriff (PDF)

A whole genome screen for association in Polish multiple sclerosis patients

Journal of neuroimmunology, 2003-10, Vol.143 (1), p.107-111

2003

Volltextzugriff (PDF)

gamma delta T Cells Enhance the Expression of Experimental Autoimmune Encephalomyelitis by Promoting Antigen Presentation and IL-12 Production

The Journal of immunology (1950), 2004-07, Vol.173 (1), p.682-694

2004

Volltextzugriff (PDF)

Microarray gene expression profiling of chronic active and inactive lesions in multiple sclerosis

Clinical neurology and neurosurgery, 2004-06, Vol.106 (3), p.223-229

2004

Volltextzugriff (PDF)

Brain-Derived Heat Shock Protein 70-Peptide Complexes Induce NK Cell-Dependent Tolerance to Experimental Autoimmune Encephalomyelitis

Journal of Immunology, 2006-02, Vol.176 (3), p.1588-1599

2006

Volltextzugriff (PDF)

Multiple sclerosis and the CTLA4 autoimmunity polymorphism CT60: no association in patients from Germany; Hungary and Poland

Multiple sclerosis, 2008-03, Vol.14 (2), p.153-158

2008

Volltextzugriff (PDF)

Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis : a multicentre, randomised, double-blind, placebo-controlled phase IIb study. Commentary

The Lancet (British edition), 2008, Vol.371 (9630)

2008

Volltextzugriff (PDF)

Intercellular adhesion molecule-1 K/E 469 polymorphism and multiple sclerosis

Annals of neurology, 1999-04, Vol.45 (4), p.546-546

1999

Volltextzugriff (PDF)

Immune reactivity to heat-shock proteins

Journal of neuroimmunology, 1995, Vol.56, p.10-10

1995

Volltextzugriff (PDF)

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

The New England journal of medicine, 2017-01, Vol.376 (3), p.221-234

2017

Volltextzugriff (PDF)

1 – 25 von 74

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(74)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(56)
Science & Technology
(56)
Humans
(49)
Multiple Sclerosis
(37)
Neurosciences & Neurology
(37)
Female
(33)
Clinical Neurology
(32)
Adult
(30)
Male
(29)
Neurology
(28)
Biological And Medical Sciences
(26)
Magnetic Resonance Imaging
(24)
Medical Sciences
(23)
Middle Aged
(21)
Multiple Sclerosis, Relapsing-Remitting - Drug Therapy
(19)
Double-Blind Method
(18)
Brain - Pathology
(17)
Neurosciences
(17)
Treatment Outcome
(15)
Disability Evaluation
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trial

cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity

Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity

Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor

Tumour necrosis factor and anti-tumour necrosis factor approach to inflammatory demyelinating diseases of the central nervous system

Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro

Multiple sclerosis: The increased frequency of the ICAM-1 exon 6 gene point mutation genetic type K469

Proton magnetic resonance spectroscopy of normal appearing white matter in familial and sporadic multiple sclerosis

Inducible Heat Shock Protein 70 Promotes Myelin Autoantigen Presentation by the HLA Class II

Shedding of TNF receptors in multiple sclerosis patients

Brain glycolipids suppress T helper cells and inhibit autoimmune demyelination

Heat shock protein 70 associations with myelin basic protein and proteolipid protein in multiple sclerosis brains

P486 Treatment-emergent COVID-19 infections in ozanimod ulcerative colitis and multiple sclerosis clinical trials

Experimental autoimmune encephalomyelitis: immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors

Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study

A whole genome screen for association in Polish multiple sclerosis patients

gamma delta T Cells Enhance the Expression of Experimental Autoimmune Encephalomyelitis by Promoting Antigen Presentation and IL-12 Production

Microarray gene expression profiling of chronic active and inactive lesions in multiple sclerosis

Brain-Derived Heat Shock Protein 70-Peptide Complexes Induce NK Cell-Dependent Tolerance to Experimental Autoimmune Encephalomyelitis

Multiple sclerosis and the CTLA4 autoimmunity polymorphism CT60: no association in patients from Germany; Hungary and Poland

Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis : a multicentre, randomised, double-blind, placebo-controlled phase IIb study. Commentary

Intercellular adhesion molecule-1 K/E 469 polymorphism and multiple sclerosis

Immune reactivity to heat-shock proteins

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

Suchergebnisse filtern